Drug Trials Snapshots: BALVERSA

BALVERSA is a drug for the treatment of a type of bladder and urinary tract cancer called urothelial carcinoma. BALVERSA may be used in patients with urothelial carcinoma: whose tumors have a certain type of abnormal (FGFR) gene and whose cancer has spread (locally advanced or metastatic urothelial
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news